RT Journal Article
SR Electronic
T1 Disentangling network topology and pathogen spread
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.24.21257706
DO 10.1101/2021.05.24.21257706
A1 Pérez-Ortiz, María
A1 Manescu, Petru
A1 Caccioli, Fabio
A1 Fernández-Reyes, Delmiro
A1 Nachev, Parashkev
A1 Shawe-Taylor, John
YR 2021
UL http://medrxiv.org/content/early/2021/05/26/2021.05.24.21257706.abstract
AB How do we best constrain social interactions to prevent the transmission of communicable respiratory diseases? Indiscriminate suppression, the currently accepted answer, is both unsustainable long term and implausibly presupposes all interactions to carry equal weight. Transmission within a social network is determined by the topology of its graphical structure, of which the number of interactions is only one aspect. Here we deploy large-scale numerical simulations to quantify the impact on pathogen transmission of a set of topological features covering the parameter space of realistic possibility. We first test through a series of stochastic simulations the differences in the spread of disease on several classes of network geometry (including highly skewed networks and small world). We then aim to characterise the spread based on the characteristics of the network topology using regression analysis, highlighting some of the network metrics that influence the spread the most. For this, we build a dataset composed of more than 9000 social networks and 30 topological network metrics. We find that pathogen spread is optimally reduced by limiting specific kinds of social contact – unfamiliar and long range – rather than their global number. Our results compel a revaluation of social interventions in communicable diseases, and the optimal approach to crafting them.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is generated via simulations. The code and dataset will be made available at https://github.com/mperezortiz/topology_spread